ALCUNI BREVETTI DELLA RICERCATRICE LUISA GAROFANO (mh ok)

Brevetti di Luisa Garofano

Luisa Garofano ha depositato brevetti per proteggere le seguenti invenzioni. Questo elenco include domande di brevetto in attesa e brevetti che sono già stati concessi dall'Ufficio brevetti e marchi degli Stati Uniti (USPTO).

https://patents.justia.com/inventor/luisa-garofano

Patents by Inventor Luisa Garofano

Luisa Garofano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

• Anthracycline glycosides

  Patent number: 6187758

  Abstract: An anthracycline glycoside of formula I wherein R is one of the two following residues: or a pharmaceutically acceptable salt thereof.

  Type: Grant

  Filed: August 27, 1999

  Date of Patent: February 13, 2001

  Assignee: Pharmacia & Upjohn S.p.A.

  Inventors: Cinzia Portello, Emanuele Arlandini, Umberto Breme, Anna Luisa Colombo, Giuliano Franchi, Giuliano Oronzo, Marco Tató, Luisa Garofano, Marina Ciomei

• Isolation and characterisation of genes resistant to anthracycline antibiotics

  Patent number: 5665564

  Abstract: Doxorubicin resistance can be conferred on a host by transforming the host with a recombinant vector comprising a DNA having the configuration of restriction sites shown in FIGS. 1 or 2 of the accompanying drawings or a restriction fragment derived therefrom containing a gene coding for doxorubicin resistance.

  Type: Grant

  Filed: August 9, 1993

  Date of Patent: September 9, 1997

  Assignee: Pharmacia & Upjohn S.p.A.

  Inventors: Marinella Caruso, Anna Luisa Colombo, Luisa Garofano, Francesca Torti, Guiseppe Zanella

• Synergistic composition comprising a fibroblast growth factor and a sulfated polysaccharide, for use as antiviral agent

  Patent number: 5288704

  Abstract: A pharmaceutcial composition is provided for use in the prevention or treatment of viral infections caused by enveloped viruses. The composition comprises a fibroblast growth factor, a sulfated polysaccharide with antiviral activity, and one or more pharmaceutically acceptable carriers. The fibroblast growth factor may be a basic fibroblast growth factor or an analogue thereof, and the polysaccharide may be a carrageenan, heparin, dextran sulfate, pentosan polysulfate or a sulfated polysaccharides produced by marine algae belonging to the class of Rhodophyceae.

  Type: Grant

  Filed: January 31, 1992

  Date of Patent: February 22, 1994

  Assignee: Farmitalia Carlo Erba S.R.L.

  Inventors: Domenico Ungheri, Luisa Garofano, Carlo Battistini, Paolo Carminati, Guy Mazue